Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Johann E Gudjonsson Md Phd

Clinical trials sponsored by Johann E Gudjonsson Md Phd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • Scientists probe whether lebrikizumab rewires diseased skin at the molecular level Results expected Jul 2027 (estimated)
Browse trials soon ready across all sponsors →
Not yet finished but already full! 1
Sort by
  • Scientists probe whether lebrikizumab rewires diseased skin at the molecular level

    Disease control Ongoing

    Researchers are studying lebrikizumab, an approved injectable drug for atopic dermatitis, to understand how it changes skin biology over time. The trial enrolls 48 people with moderate-to-severe atopic dermatitis who have not done well on topical treatments. Participants receive …

    Phase 4 • Sponsor: Johann E Gudjonsson MD PhD • Aim: Disease control

    Last updated Sep 17, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space